Comments
Loading...

TransCode Therapeutics

RNAZNASDAQ
Logo brought to you by Benzinga Data
$3.52
-0.06-1.68%
At close: -
$3.51
-0.00670-0.19%
After Hours: 4:13 PM EDT

TransCode Therapeutics (NASDAQ:RNAZ) Stock Quotes, Forecast and News Summary

TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.

Open$3.62
Close$3.52
Volume / Avg.46.78K / 58.93K
Day Range$3.34 - $3.74
52 Wk Range3.21 - 264.00
Market Cap$2.45M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
24
Short Interest
87%
Days to Cover1.2

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Aug
1
Sep
1
Oct
1
Nov
1
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$3.62
Close$3.52
Volume / Avg.46.78K / 58.93K
Day Range$3.34 - $3.74
52 Wk Range3.21 - 264.00
Market Cap$2.45M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
24
Short Interest
87%
Days to Cover1.2

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RNAZ
ZVSA

FAQ

Q

How do I buy TransCode Therapeutics (RNAZ) stock?

A

You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TransCode Therapeutics (RNAZ) competitors?

Q

What is the forecast, or price target, for TransCode Therapeutics (RNAZ) stock?

A

TransCode Therapeutics has a consensus price target of $20.00.

Q

What is the current price for TransCode Therapeutics (RNAZ)?

A

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $3.5133 last updated December 24, 2024 at 4:13 PM EST.

Q

Does TransCode Therapeutics (RNAZ) pay a dividend?

A

There are no upcoming dividends for TransCode Therapeutics.

Q

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

A

TransCode Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Q

Is TransCode Therapeutics (RNAZ) going to split?

A

There is no upcoming split for TransCode Therapeutics.

Q

What sector and industry does TransCode Therapeutics (RNAZ) operate in?

A

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch